| Dr Peter F Koltz, MD | |
|
7634 W Central Ave, Toledo, OH 43617-1526 | |
| (567) 408-7356 | |
| (567) 408-7355 |
| Full Name | Dr Peter F Koltz |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 16 Years |
| Location | 7634 W Central Ave, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316260797 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Promedica Toledo Hospital | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Promedica Central Physicians | 2365348190 | 818 |
News Archive
Leuphana University Lueneburg will apply for an EU Innovation Project, with an investment volume of up to EUR 1.6 billion - Big Data revolution in Healthcare through focused European collaboration in the most promising application areas - Strong partnerships with the University Medical Center Goettingen and the University of Zurich as well as the Republic of Malta, Sclavo Vaccines Association of Italy and ICHOM, among others.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa.
› Verified 4 days ago
| Entity Name | Promedica Central Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043270150 PECOS PAC ID: 2365348190 Enrollment ID: O20031211000226 |
News Archive
Leuphana University Lueneburg will apply for an EU Innovation Project, with an investment volume of up to EUR 1.6 billion - Big Data revolution in Healthcare through focused European collaboration in the most promising application areas - Strong partnerships with the University Medical Center Goettingen and the University of Zurich as well as the Republic of Malta, Sclavo Vaccines Association of Italy and ICHOM, among others.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa.
› Verified 4 days ago
| Entity Name | Frank Barone M.d., Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336338235 PECOS PAC ID: 2264513019 Enrollment ID: O20080117000475 |
News Archive
Leuphana University Lueneburg will apply for an EU Innovation Project, with an investment volume of up to EUR 1.6 billion - Big Data revolution in Healthcare through focused European collaboration in the most promising application areas - Strong partnerships with the University Medical Center Goettingen and the University of Zurich as well as the Republic of Malta, Sclavo Vaccines Association of Italy and ICHOM, among others.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter F Koltz, MD 333 N Summit St Fl 7, Toledo, OH 43604-1531 Ph: (000) 000-0000 | Dr Peter F Koltz, MD 7634 W Central Ave, Toledo, OH 43617-1526 Ph: (567) 408-7356 |
News Archive
Leuphana University Lueneburg will apply for an EU Innovation Project, with an investment volume of up to EUR 1.6 billion - Big Data revolution in Healthcare through focused European collaboration in the most promising application areas - Strong partnerships with the University Medical Center Goettingen and the University of Zurich as well as the Republic of Malta, Sclavo Vaccines Association of Italy and ICHOM, among others.
Researchers have developed a soft neural implant that can be wirelessly controlled using a smartphone. It is the first wireless neural device capable of indefinitely delivering multiple drugs and multiple color lights, which neuroscientists believe can speed up efforts to uncover brain diseases such as Parkinson's, Alzheimer's, addiction, depression, and pain.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2010. For the quarter ended March 31, 2010, Orexigen reported a net loss of $14.1 million, or $0.30 per share attributable to common stockholders, as compared to a net loss of $19.3 million, or $0.56 per share attributable to common stockholders, for the first quarter of 2009.
CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa.
› Verified 4 days ago
Dr. Frank E Barone, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2000 Regency Ct, Ste 204, Toledo, OH 43623 Phone: 419-720-2008 Fax: 419-720-2009 | |
Luis H Carvalho, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3438 Granite Cir, Toledo, OH 43617 Phone: 419-841-2303 Fax: 419-842-1161 | |
Mrs. Lauralee Basch, R.N.F.A Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2865 N Reynolds Rd, Ste 250, Toledo, OH 43615 Phone: 419-534-6551 Fax: 419-534-6563 | |
Dr. Karim A Sarhane, MD, MSC Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-6462 | |
Dr. John F Zavell, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2865 N Reynolds Rd, Ste 250, Toledo, OH 43615 Phone: 419-534-6551 Fax: 419-534-6563 | |
Dr. Craig W Colville, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2865 N Reynolds Rd, Ste 250, Toledo, OH 43615 Phone: 419-534-6551 Fax: 419-534-6563 |